Filing metadata

Accession number
0001209191-21-022631
Form type
Form 4
Filer
Adamas Pharmaceuticals Inc
CIK
CIK 1328143
Filed
Mar 23, 2021
Reporting period
Mar 22, 2021
Description
Insider transaction

Explore SEC Filings Hub